Company / Accounts Receivable
CROSS COUNTRY HEALTHCARE INC Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$167.5M
FY2025
5-year range
$167.5M / $641.6M
FY2021-FY2025
Trend
-25.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has declined for 3 consecutive years, from $642M in FY2022 to $168M in FY2025.
Based on SEC 10-K filings.
$168M in FY2025 with a 5-year CAGR of -0.3%.
Declined from $372M to $168M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -36.1%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- CROSS COUNTRY HEALTHCARE INC's accounts receivable has declined for 3 consecutive years.
- 5-year CAGR of -0.3%, indicating a declining trend.
- In FY2025, accounts receivable decreased 25.0% year-over-year.
- Peak accounts receivable was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $167.5M | -25.0% |
| FY2024 | $223.2M | -40.0% |
| FY2023 | $372.4M | -42.0% |
| FY2022 | $641.6M | +29.9% |
| FY2021 | $493.9M | +190.5% |
| FY2020 | $170.0M | +0.3% |
| FY2019 | $169.5M | +2.0% |
| FY2018 | $166.1M | -4.3% |
| FY2017 | $173.6M | -0.0% |
| FY2016 | $173.6M | +18.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026